Emergent CDMO is dedicated to helping biopharmaceutical innovators bring lifesaving therapies to patients globally. We offer a wide range of technologies including mammalian, microbial, viral, plasma, and gene therapies. Our development services, drug substance, and drug product manufacturing teams stand ready to support your project from preclinical to commercialization.